Amgen Stock Rises on Pipeline Expansion and Strong Q4 Results
Mar 03, 2026
Amgen shares have climbed 35% over six months, trading near $388, as analysts raise price targets following strong fourth-quarter 2025 results and expanding oncology pipeline programs including IMDELLTRA and LUMAKRAS.